GlassScriptPhysician profile
Anh Huu Pham
NPI 1750325361
$995.31
in general payments reported to CMS, 2019-2025
7 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $72.93 · 2021: $110 · 2023: $136 · 2024: $334 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $525 · Food and Beverage: $94.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $525.00 |
| Food and Beverage | $94.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $539.91 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $173.83 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $128.89 | 2019 | |
| Septodont INC. | $72.93 | 2020 | |
| 3m Company | $46.05 | 2023 | Clarity Advanced, Transbond Xt, Transbond Plus |
| Pacira Pharmaceuticals Incorporated | $17.55 | 2024 | Exparel |
| Solventum Corporation | $16.15 | 2024 | Apc Flash-Free Victory Series Low Profile, Apc II Victory Series |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anh Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.